Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Talcum Powder Injury Lawyers Oppose J&J’s Attempt To Further Delay Litigation By Rearguing Expert Challenges Plaintiffs say Johnson & Johnson wants to relitigate Daubert challenges that were decided by the Court two years ago, in yet another attempt to prevent individuals dying of cancer from receiving compensation. August 25, 2023 Irvin Jackson Add Your Comments Following two failed bankruptcy attempts and a nearly two year stay on all progress in thousands of talcum powder lawsuits being pursued by women diagnosed with ovarian cancer, plaintiff’s lawyers are urging the U.S. District Judge recently appointed to preside over the litigation to reject yet another delay tactic by Johnson & Johnson, which seeks to reargue expert witness challenges that were already decided by the previous judge assigned to the cases. Johnson & Johnson faces more than 60,000 Baby powder lawsuits and Shower-to-Shower lawsuits filed throughout the federal court system, each involving similar allegations that asbestos particles in the talc-based products caused users to develop ovarian cancer, mesothelioma, and other injuries. Following massive jury awards returned in cases that went to trial several years ago, the manufacturer decided to initiate a controversial talcum powder bankruptcy scheme in 2021, as part of an attempt to force any settlement for the cases through the U.S. bankruptcy system. Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Until this month, plaintiffs have been barred from filing new talcum powder claims under a bankruptcy stay, and additional bellwether trials expected to begin nearly two years ago have been on hold while challenges were filed to the bankruptcy. Although Johnson & Johnson has billions of assets on hand, the company attempted a maneuver known as the “Texas Two Step” in 2021, by transferring all liability it faced in the litigation to a new subsidiary, LTL Management, LLC, which then immediately filed for bankruptcy protection. Following several years of challenges to the filing, the Third Circuit Court of Appeals ultimately rejected that initial bankruptcy filing in March 2023, finding that LTL Management faced no real financial distress. Just as the litigation was set to get underway once again earlier this year, Johnson & Johnson immediately initiated a second bankruptcy filing, as part of a proposed $8.9 billion talcum powder settlement fund that it hoped to use to force all current and future plaintiffs to resolve their claims through the U.S. bankruptcy system. However, plaintiffs objected to the move, claiming it would force individuals diagnosed with cancer to accept minimal offers for their claims, and prevent all future individuals injured by talcum powder from pursuing a lawsuit through the civil court system. Last month, U.S. Bankruptcy Judge Michael B. Kaplan rejected the second talcum powder bankruptcy, after determining that it was “filed in bad faith” and that LTL Management still did not face financial distress requiring bankruptcy protections. Therefore, active litigation is set to get underway again in a federal talcum powder MDL, which was initially established in 2016. The litigation was initially assigned to U.S. District Judge Freda Wolfson, who announced her retirement earlier this year. Therefore, Judge Michael Shipp was appointed to preside over further management of the talcum powder lawsuits. Talcum Powder Injury Lawyers Push Back Against Further Delays In recent court filings, plaintiffs’ attorneys have noted that many individuals who have filed talcum powder lawsuits face life-threatening cancer diagnoses, and some have died while waiting for their day in court due to Johnson & Johnson’s rejected delaying tactics. They are now trying to prevent further delays by pushing back against what they say are plans for Johnson & Johnson to again challenge expert witness testimony, despite Judge Wolfson previously ruling on those challenges years ago. Their objections to Johnson & Johnson’s plans to reargue Daubert motions were outlined in a letter (PDF) to the court issued on August 23. “After delaying this MDL litigation for nearly two years via multiple failed bankruptcy efforts, Defendants seek to further delay bellwether trials by redoing that which has already been done in this case,” talcum powder injury lawyers wrote. “Although it is acceptable for the court to ‘at least a limited review of the expert’s conclusions ‘in order to determine whether they could reliably flow from the facts known to the expert and the methodology used,’ neither the passage of time nor the publication of new literature undermines the sound methodologies employed or conclusions reached by Plaintiffs’ experts.” Plaintiffs filed a proposed scheduling order along with the letter, which details how they will respond to requests to produce records for discovery over the next several months, if the Court refuses Johnson & Johnson’s request to reargue expert witness challenges. Plaintiffs Push For No Further Delays in Talcum Powder Lawsuits Prior to the initial talcum powder lawsuit bankruptcy stay, the parties were planning for a series of early bellwether trials to be held, to help gauge how juries are likely to respond to certain evidence and testimony that is likely to be repeated throughout the litigation. To make up for lost time, plaintiffs are now pushing the court to quickly resume trial prep. In August, plaintiffs sent another letter to Judge Shipp, calling for the Court to begin moving the cases toward trial “expeditiously.” In response, Judge Shipp issued a docket order scheduling a status conference for September 6. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Asbestos, Baby Powder, Bankruptcy, Cancer, Johnson & Johnson, Ovarian Cancer, Shower to Shower, Talcum Powder More Talcum Powder Lawsuit Stories Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 August 27, 2025 Women Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court August 7, 2025 Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family August 1, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermInstagramThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: 2 days ago) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: 3 days ago) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 4 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)